articles
- The molecular underpinning of geminin-overexpressing triple-negative breast cancer cells homing specifically to lungs 2021
- Clinical analysis of NSCLC patients reveals lack of association between EGFR mutation and TET1 downregulation. 24:373-380. 2017
- The combination of i-leader truncation and gemcitabine improves oncolytic adenovirus efficacy in an immunocompetent model. 21:68-73. 2014
- The antitumor effects of adenoviral-mediated, intratumoral delivery of interleukin 23 require endogenous IL-12. 19:135-143. 2012
- Adenoviral-mediated, intratumor gene transfer of interleukin 23 induces a therapeutic antitumor response. 16:776-785. 2009
- Targeting of products of genes to tumor sites using adoptively transferred a-nk and t-lak cells. 14:441-450. 2007
- Mapping of angiogenic markers for targeting of vectors to tumor vascular endothelial cells. 14:346-353. 2007
- Potent antitumor effects of intra-arterial injection of fibroblasts genetically engineered to express IL-12 in liver metastasis model of rat: No additional benefit of using retroviral producer cell. 8:17-22. 2001
- Induction of antitumor immunity by direct intratumoral injection of a recombinant adenovirus vector expressing interleukin-12. 6:45-53. 1999
- Induction of tumor antigen-specific immunity using plasmid DNA immunization in mice. 6:73-80. 1999
- Enhancement of antitumor immunity by expression of CD70 (CD27 ligand) or CD154 (CD40 ligand) costimulatory molecules in tumor cells. 5:163-175. 1998